
Elizabeth A. Burkhart
Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )
| Most Active Art Unit | 1715 |
| Art Unit(s) | 1762, 1715, 1792 |
| Total Applications | 919 |
| Issued Applications | 503 |
| Pending Applications | 11 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1046852
[patent_doc_number] => 06864247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'Therapeutic agents for glomerulosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/314389
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 2153
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314389 | Therapeutic agents for glomerulosclerosis | Dec 8, 2002 | Issued |
Array
(
[id] => 7288560
[patent_doc_number] => 20040109824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Particles for imaging cells'
[patent_app_type] => new
[patent_app_number] => 10/313304
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7955
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20040109824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313304 | Particles for imaging cells | Dec 5, 2002 | Abandoned |
Array
(
[id] => 1098303
[patent_doc_number] => 06818201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-16
[patent_title] => 'Vitronectin receptor antagonist pharmaceuticals'
[patent_app_type] => B2
[patent_app_number] => 10/306244
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41592
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306244 | Vitronectin receptor antagonist pharmaceuticals | Nov 25, 2002 | Issued |
Array
(
[id] => 689853
[patent_doc_number] => 07074386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-11
[patent_title] => 'Pressure induced swelling in microporous materials'
[patent_app_type] => utility
[patent_app_number] => 10/303169
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 13902
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/074/07074386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10303169
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303169 | Pressure induced swelling in microporous materials | Nov 24, 2002 | Issued |
Array
(
[id] => 6710424
[patent_doc_number] => 20030170173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Contrast agents'
[patent_app_type] => new
[patent_app_number] => 10/302419
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19615
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302419
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302419 | Contrast agents | Nov 21, 2002 | Abandoned |
Array
(
[id] => 6855635
[patent_doc_number] => 20030129136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods for targeted drug delivery'
[patent_app_type] => new
[patent_app_number] => 10/302369
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14004
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302369
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302369 | Methods for targeted drug delivery | Nov 21, 2002 | Issued |
Array
(
[id] => 797805
[patent_doc_number] => 07427391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'Formulations for use in medical and diagnostic procedures'
[patent_app_type] => utility
[patent_app_number] => 10/476314
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8720
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476314 | Formulations for use in medical and diagnostic procedures | Nov 20, 2002 | Issued |
Array
(
[id] => 7395391
[patent_doc_number] => 20040022732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Microparticles based on aspartic acid and use thereof as mri contrast agents'
[patent_app_type] => new
[patent_app_number] => 10/148867
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4984
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20040022732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148867 | Microparticles based on aspartic acid and use thereof as mri contrast agents | Nov 12, 2002 | Abandoned |
Array
(
[id] => 793278
[patent_doc_number] => 06982324
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 10/288618
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4143
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288618 | Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof | Nov 4, 2002 | Issued |
Array
(
[id] => 7389594
[patent_doc_number] => 20040037778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Radio-opaque polymeric biomaterials'
[patent_app_type] => new
[patent_app_number] => 10/288076
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11111
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288076 | Radio-opaque polymeric biomaterials | Nov 4, 2002 | Issued |
Array
(
[id] => 6701055
[patent_doc_number] => 20030223935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Fluorescent membrane intercalating probes and methods for their use'
[patent_app_type] => new
[patent_app_number] => 10/220241
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9349
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20030223935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220241 | Fluorescent membrane intercalating probes and methods for their use | Oct 31, 2002 | Abandoned |
Array
(
[id] => 6678966
[patent_doc_number] => 20030229107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Magnetic resonance with stimulation'
[patent_app_type] => new
[patent_app_number] => 10/286349
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3661
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286349 | Magnetic resonance with stimulation | Oct 31, 2002 | Abandoned |
Array
(
[id] => 7469269
[patent_doc_number] => 20040102422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Cancer therapy'
[patent_app_type] => new
[patent_app_number] => 10/284732
[patent_app_country] => US
[patent_app_date] => 2002-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4191
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10284732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/284732 | Cancer therapy | Oct 30, 2002 | Abandoned |
Array
(
[id] => 971855
[patent_doc_number] => 06936240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Method for the preparation of technetium or rhenium complex for radiopharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 10/287133
[patent_app_country] => US
[patent_app_date] => 2002-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 28
[patent_no_of_words] => 6493
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287133 | Method for the preparation of technetium or rhenium complex for radiopharmaceuticals | Oct 30, 2002 | Issued |
Array
(
[id] => 7311986
[patent_doc_number] => 20040033200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Modified FVII in treatment of ARDS'
[patent_app_type] => new
[patent_app_number] => 10/283482
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15966
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033200.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283482 | Modified FVII in treatment of ARDS | Oct 29, 2002 | Abandoned |
Array
(
[id] => 627112
[patent_doc_number] => 07135496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-14
[patent_title] => 'Water soluble paclitaxel derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/282490
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21839
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10282490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/282490 | Water soluble paclitaxel derivatives | Oct 27, 2002 | Issued |
Array
(
[id] => 6668353
[patent_doc_number] => 20030113336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Vitronectin receptor antagonist pharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/281015
[patent_app_country] => US
[patent_app_date] => 2002-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60275
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113336.pdf
[firstpage_image] =>[orig_patent_app_number] => 10281015
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/281015 | Vitronectin receptor antagonist pharmaceuticals | Oct 25, 2002 | Issued |
Array
(
[id] => 6653939
[patent_doc_number] => 20030077225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Hydrophilic polymer biomaterial having a specific magnetic resonance imaging signal and process for the preparation of said biomaterial'
[patent_app_type] => new
[patent_app_number] => 10/278256
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4227
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278256 | Hydrophilic polymer biomaterial having a specific magnetic resonance imaging signal and process for the preparation of said biomaterial | Oct 22, 2002 | Issued |
Array
(
[id] => 7475375
[patent_doc_number] => 20040097735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Small technetium-99m and rhenium labeled agents and methods for imaging tumors'
[patent_app_type] => new
[patent_app_number] => 10/279214
[patent_app_country] => US
[patent_app_date] => 2002-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20797
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10279214
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/279214 | Small technetium-99m and rhenium labeled agents and methods for imaging tumors | Oct 22, 2002 | Issued |
Array
(
[id] => 948655
[patent_doc_number] => 06962690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-08
[patent_title] => 'Tissue specific fluorescent chelates possessing long wavelength UV excitation'
[patent_app_type] => utility
[patent_app_number] => 10/278584
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7303
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278584 | Tissue specific fluorescent chelates possessing long wavelength UV excitation | Oct 21, 2002 | Issued |